!-- Global site tag (gtag.js) - Google Analytics -->
Select Page

An Update on a Few of Our Stocks

Rough day out there as we write this. Dow down 140 and the S&P 500 down 20 or 0.8%.

Nutanix (NTNX: $22.40) is having a good day. It’s at the top today of all of the stocks we follow, up 3%. Just think what a good day it would be having if the market were up 140 points instead of down 140. This stock is a winner that just hasn’t been realized yet. But note that if it had been discovered, the stock would be at $40 or higher where is ought to be.

Firsthand Technology Value Fund has disclosed that Nutanix is one of its top five positions. The fund is a small fund - $140 million – but they have put 7% of the entire fund into Nutanix. That’s $10 million.

Nutanix is a provider of hyperconverged data center equipment that merges computing, storage, and networking capabilities in a single piece of equipment. More businesses are looking to adapt the technology, with 18% of chief information officers saying they expect to move to hyperconverged systems in the next two years, according to a survey by Goldman Sachs. Goldman added the stock to their conviction list, saying it has an estimated 50% return potential to their $31 price target.

Last quarter Nutanix said it gained 800 new customers, with 20 global companies buying more than $1 million in hardware or software. The larger deals helped push overall sales growth to 67%. The company got some big name wins in the quarter, including corporate giants such as Caterpillar, Kyocera, Société Générale and Sprint. One undisclosed customer win was a retailer with $50 billion in sales in the U.S.

The company’s leadership in the space, including the combination of hardware and software it offers, makes it a “once-in-a-decade tech infrastructure story,” wrote Goldman. They see Nutanix on a path for long-term double-digit growth, high gross margins and large operating leverage.

Despite its leadership in the space, the stock is down 15% year-to-date. “The stock drop and Nutanix’s unique position in the space, however, make it a prime acquisition target,” Goldman said.

BMR Take: We like this company. Growth in revenues always wins out in the end.

Shopify (SHOP: $95) and Twilio (TWLO: $31) are both up slightly today too, even as the market is not having a good day. That sends us a strong message of confidence.

 

 

 

 

MYLAN ADDED TO OPPORTUNITIES IN HEALTHCARE

July 12, 2016: The United States pays the highest prices for prescription drugs of any country in the world. New drugs enjoy long patent protection that allows their makers to set prices at whatever the market will bear. It doesn’t stop there.

This content is for our beloved subscribers and anything you see on this page is just an excerpt!

Please note BullMarket.com access is available to paid subscribers only. Our Members Areas include archives of past Newsletters, News Flashes, our eight portfolios including STOCKS FOR SUCCESS, Healthcare, High Yield, High Technology, Aggressive, Real Estate Investment Trusts, Long Term Growth, and Special Opportunities. Also, all of our in-depth research is available, and more.

Already a subscriber?

Ready to join?
Subscribe Now!

CBRE and BREXIT

June 29, 2016: CBRE (CBG: $26, up 3% today) The global leader in real estate services has seen its stock hammered by the Brexit decision. Just this month, the price has fallen from $31, just before the Brexit vote, by 20% to its low on Monday to just under $25. Is this justified? The answer is no and here is why.

This content is for our beloved subscribers and anything you see on this page is just an excerpt!

Please note BullMarket.com access is available to paid subscribers only. Our Members Areas include archives of past Newsletters, News Flashes, our eight portfolios including STOCKS FOR SUCCESS, Healthcare, High Yield, High Technology, Aggressive, Real Estate Investment Trusts, Long Term Growth, and Special Opportunities. Also, all of our in-depth research is available, and more.

Already a subscriber?

Ready to join?
Subscribe Now!

CELGENE ADDED TO OPPORTUNITIES IN HEALTHCARE

June 27, 2016: Biotech Has Been A Barking Dog. Biotechnology promises to change the fight against major diseases, remove pain and suffering, create high paying jobs and provide prosperity for business and investors. So far many of these promises have come to pass. Even more great health benefits are in store for the future. There is, however, one big thing missing.

This content is for our beloved subscribers and anything you see on this page is just an excerpt!

Please note BullMarket.com access is available to paid subscribers only. Our Members Areas include archives of past Newsletters, News Flashes, our eight portfolios including STOCKS FOR SUCCESS, Healthcare, High Yield, High Technology, Aggressive, Real Estate Investment Trusts, Long Term Growth, and Special Opportunities. Also, all of our in-depth research is available, and more.

Already a subscriber?

Ready to join?
Subscribe Now!

TESLA IS BUYING SOLAR CITY

June 22, 2016: Tesla (TSLA: $220) announced a buyout offer for Solar City (SCTY: $21). Tesla is down to $193 in afterhours trading and Solar City is up to $24, after hitting $25.

This content is for our beloved subscribers and anything you see on this page is just an excerpt!

Please note BullMarket.com access is available to paid subscribers only. Our Members Areas include archives of past Newsletters, News Flashes, our eight portfolios including STOCKS FOR SUCCESS, Healthcare, High Yield, High Technology, Aggressive, Real Estate Investment Trusts, Long Term Growth, and Special Opportunities. Also, all of our in-depth research is available, and more.

Already a subscriber?

Ready to join?
Subscribe Now!